BiotechTube
Home/Nymox Pharmaceutical/Claus G. Roehrborn
CG

Claus G. Roehrborn

Key Clinical Investigator (from publications)

Nymox Pharmaceutical

Therapeutic Areas

UrologyOncology

Nymox Pharmaceutical Pipeline

DrugIndicationPhase
Fexapotide Triflutate (NX-1207)Benign Prostatic Hyperplasia (BPH)Phase 3

Leadership Team at Nymox Pharmaceutical

PA
Paul Averback
Founder
NS
Neal Shore
Key Clinical Investigator (from publications)
RT
Ronald Tutrone
Key Clinical Investigator (from publications)
View full Nymox Pharmaceutical profile